These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15123665)

  • 1. Peptide inhibition of catalytic and noncatalytic activities of matrix metalloproteinase-9 blocks tumor cell migration and invasion.
    Björklund M; Heikkilä P; Koivunen E
    J Biol Chem; 2004 Jul; 279(28):29589-97. PubMed ID: 15123665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a negatively charged peptide motif within the catalytic domain of progelatinases that mediates binding to leukocyte beta 2 integrins.
    Stefanidakis M; Bjorklund M; Ihanus E; Gahmberg CG; Koivunen E
    J Biol Chem; 2003 Sep; 278(36):34674-84. PubMed ID: 12824186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The integrin cytoplasmic-tail motif EKQKVDLSTDC is sufficient to promote tumor cell invasion mediated by matrix metalloproteinase (MMP)-2 or MMP-9.
    Morgan MR; Thomas GJ; Russell A; Hart IR; Marshall JF
    J Biol Chem; 2004 Jun; 279(25):26533-9. PubMed ID: 15067014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1.
    Wei Y; Eble JA; Wang Z; Kreidberg JA; Chapman HA
    Mol Biol Cell; 2001 Oct; 12(10):2975-86. PubMed ID: 11598185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dentin matrix protein 1 enhances invasion potential of colon cancer cells by bridging matrix metalloproteinase-9 to integrins and CD44.
    Karadag A; Fedarko NS; Fisher LW
    Cancer Res; 2005 Dec; 65(24):11545-52. PubMed ID: 16357164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMP-9, uPAR and cathepsin B silencing downregulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice.
    Veeravalli KK; Chetty C; Ponnala S; Gondi CS; Lakka SS; Fassett D; Klopfenstein JD; Dinh DH; Gujrati M; Rao JS
    PLoS One; 2010 Jul; 5(7):e11583. PubMed ID: 20657647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of nitric oxide synthase in matrix metalloproteinase-9- and/or urokinase plasminogen activator receptor-mediated glioma cell migration.
    Zhuang T; Chelluboina B; Ponnala S; Velpula KK; Rehman AA; Chetty C; Zakharian E; Rao JS; Veeravalli KK
    BMC Cancer; 2013 Dec; 13():590. PubMed ID: 24325546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro-collagenase-1 (matrix metalloproteinase-1) binds the alpha(2)beta(1) integrin upon release from keratinocytes migrating on type I collagen.
    Dumin JA; Dickeson SK; Stricker TP; Bhattacharyya-Pakrasi M; Roby JD; Santoro SA; Parks WC
    J Biol Chem; 2001 Aug; 276(31):29368-74. PubMed ID: 11359786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1.
    Lamfers ML; Grimbergen JM; Aalders MC; Havenga MJ; de Vries MR; Huisman LG; van Hinsbergh VW; Quax PH
    Circ Res; 2002 Nov; 91(10):945-52. PubMed ID: 12433840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the Hemopexin-like Domain of Latent Matrix Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor Prevents the Formation of Focal Adhesion Junctions.
    Alford VM; Kamath A; Ren X; Kumar K; Gan Q; Awwa M; Tong M; Seeliger MA; Cao J; Ojima I; Sampson NS
    ACS Chem Biol; 2017 Nov; 12(11):2788-2803. PubMed ID: 28945333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.
    Sun LC; Luo J; Mackey LV; Fuselier JA; Coy DH
    Cancer Lett; 2007 Feb; 246(1-2):157-66. PubMed ID: 16644105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional mimetic peptide discovery isolated by phage display interacts selectively to fibronectin domain and inhibits gelatinase.
    Shoari A; Rasaee MJ; Kanavi MR; Daraei B
    J Cell Biochem; 2019 Dec; 120(12):19699-19711. PubMed ID: 31270859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase receptor mediates lung fibroblast attachment and migration toward provisional matrix proteins through interaction with multiple integrins.
    Zhu S; Gladson CL; White KE; Ding Q; Stewart J; Jin TH; Chapman HA; Olman MA
    Am J Physiol Lung Cell Mol Physiol; 2009 Jul; 297(1):L97-108. PubMed ID: 19411312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.
    Tummalapalli P; Gondi CS; Dinh DH; Gujrati M; Rao JS
    Int J Oncol; 2007 Jul; 31(1):5-17. PubMed ID: 17549400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular determinants of glioma cell migration and invasion.
    Wild-Bode C; Weller M; Wick W
    J Neurosurg; 2001 Jun; 94(6):978-84. PubMed ID: 11409528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation.
    Kjøller L; Kanse SM; Kirkegaard T; Rodenburg KW; Rønne E; Goodman SL; Preissner KT; Ossowski L; Andreasen PA
    Exp Cell Res; 1997 May; 232(2):420-9. PubMed ID: 9168821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and alpha v beta 5 integrin.
    Franco P; Vocca I; Carriero MV; Alfano D; Cito L; Longanesi-Cattani I; Grieco P; Ossowski L; Stoppelli MP
    J Cell Sci; 2006 Aug; 119(Pt 16):3424-34. PubMed ID: 16882693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase.
    Deryugina EI; Bourdon MA; Jungwirth K; Smith JW; Strongin AY
    Int J Cancer; 2000 Apr; 86(1):15-23. PubMed ID: 10728589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of matrix metalloproteinase-9 dimers in cell migration: design of inhibitory peptides.
    Dufour A; Zucker S; Sampson NS; Kuscu C; Cao J
    J Biol Chem; 2010 Nov; 285(46):35944-56. PubMed ID: 20837483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor type 1 promotes fibrosarcoma cell migration by modifying cellular attachment to vitronectin via alpha(v)beta(5) integrin.
    Takahashi T; Suzuki K; Ihara H; Mogami H; Kazui T; Urano T
    Semin Thromb Hemost; 2005 Jun; 31(3):356-63. PubMed ID: 16052409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.